Companies
Aspen Pharmacare sees weight-loss drugs driving earnings
South African drugmaker Aspen Pharmacare said the rollout of its weight-loss drugs will help drive a 17% rise in earnings next year. Aspen sells Mounjaro, the weight-loss drug made by US manufacturer Eli Lilly, in South Africa. It will begin offering its own generic drug, targeting local markets as well as South…
Semafor AfricaBy Alexander Onukwue
Share

Read the full story
Africa Business Review aggregates and summarises reporting from trusted publishers. The full article is published by Semafor Africa.
Read at Semafor Africa →Original headline: “Aspen Pharmacare sees weight-loss drugs driving earnings”
- Africa